Obermatt
See Similar Stocks →

Raffles Medical Group

SES:BSL · SG1CH4000003
Health Care Providers & ServicesMedium

360

70
EV / EBIT42
Price / Owner Earnings46
Owner Earnings Yield87
Dividend Yield79
Price/Sales37
EV / Gross Profit82
Price/Book50
Return on Capital49
Cash Return on Capital80
Return on Equity40
EBIT Margin57
Gross Profitability63
Cash Conversion30
Accruals57
Owner Earnings Margin85
Sales growth30
Profit Growth53
Long-Term EPS Growth48
Owner Earnings Growth46
Reinvestment100
Price momentum70
Debt load59
Refinancing8
Debt Payback100
Liquidity63
Analyst ratings90
Opinion Changes50
Price Target Upside67
Market mood79
Value Creation16/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Raffles Medical Group generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountrySingapore
IndustryHealth Care Providers & Services
SizeMedium
TypePublic Company
ExchangeSGX
Founded1989
Employees852
Websiterafflesmedicalgroup.com
ISINSG1CH4000003
Last UpdateApr 2, 2026
Index & Theme
Outpatient CareHealth DiagnosticsNutraceuticalDentistryHealth CareInsuranceMedical

Description

Raffles Medical Group Ltd is a healthcare provider in Southeast Asia, recognized for its extensive network of medical services and facilities. The company operates a diversified range of healthcare services, including medical clinics, hospitals, and…

Analysis

Middle-of-the-road

Raffles Medical Group Ltd is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is fair. You pay 17.9× its owner earnings: the cash an owner could take out each year, which is in the historically fair zone. At today's price, the market is assuming roughly 5% yearly growth; analysts expect 7%. The price, in other words, assumes less than the experts do.

The trajectory is moderate and the balance sheet is sturdy. The company scores 16/20 on our value-creation score: strong value creator.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
74
2023202420252026

All-time high

89

Jan 2023

All-time low

10

Jan 2025

Average rank

50

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
37
43
37
41
Price/Earnings
35
34
34
25
Price/Book
50
54
37
49
Dividend Yield
79
85
78
54
Value (overall)
50
49
41
43

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Raffles Medical Group with its peers
Ansell
ASX:ANN
80
CountryAustralia
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Ramsay Health Care
ASX:RHC
15
CountryAustralia
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
Australian Clinical Labs
ASX:ACL
65
CountryAustralia
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Ebos
NZC:EBO
40
CountryAustralia
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
AS ONE
TYO:7476
80
CountryJapan
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Integral Diagnostics
ASX:IDX
45
CountryAustralia
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →